Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,770 | Dovepress* | 3,542+ | 118 | 3,660 | |
| PubMed Central* | 228 | 127 | 355 | ||
| Totals | 3,770 | 245 | 4,015 | ||
| *Since 14 December 2022 | |||||
View citations on PubMed Central and Google Scholar